Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work? (Q37709432)

From Wikidata

Jump to navigation Jump to search

scientific article published on 05 January 2010

Language	Label	Description	Also known as
English	Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?	scientific article published on 05 January 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work? (English)

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

nephrotic syndrome

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Giuseppe Remuzzi

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Piero Ruggenenti

3

object named as

Piero Ruggenenti

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Varusca Brusegan

2

object named as

Varusca Brusegan

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Ruth Campbell

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

5 January 2010

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Pharmaceuticals

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1-9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

copyright license

Creative Commons Attribution 4.0 International

5 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Aldosterone antagonists for preventing the progression of chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991017

23 August 2017

Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991017

23 August 2017

Intensified inhibition of renin-angiotensin system: a way to improve renal protection?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991017

23 August 2017

Aldosterone receptor blockade and the role of eplerenone: evolving perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991017

23 August 2017

Aldosterone in chronic kidney and cardiac disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991017

23 August 2017

Role of aldosterone in the remnant kidney model in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991017

23 August 2017

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991017

23 June 2018

Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease

1 reference

https://api.crossref.org/works/10.3390%2FPH3010001

21 January 2018

The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study

1 reference

https://api.crossref.org/works/10.3390%2FPH3010001

21 January 2018

Rituximab in idiopathic membranous nephropathy: a one-year prospective study

1 reference

https://api.crossref.org/works/10.3390%2FPH3010001

21 January 2018

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.3390%2FPH3010001

21 January 2018

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.3390%2FPH3010001

21 January 2018

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases

1 reference

https://api.crossref.org/works/10.3390%2FPH3010001

21 January 2018

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.3390%2FPH3010001

21 January 2018

Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/27713239

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/27713239

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/27713239

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level

1 reference

https://pubmed.ncbi.nlm.nih.gov/27713239

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3390/PH3010001

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27713239%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37709432&oldid=2092018551"